新功能、新界面、新体验,扫描即可下载生物谷APP!
首页 » 生物研究 » Adv Wound Care:IL-10或作为一种抗瘢痕形成剂

Adv Wound Care:IL-10或作为一种抗瘢痕形成剂

来源:生物谷 2014-05-11 20:40

2014年5月11日讯 /生物谷BIOON/--近日,一项科学研究证实了强大的抗炎化合物白细胞介素-10(IL-10)在胎儿皮肤再生、无瘢痕愈合中起着至关重要的作用。

IL-10在产后皮肤伤口的研究证明了其可作为抗疤痕治疗剂的潜能,相关研究发表在Advances in Wound Care杂志上。

在“再生伤口愈合:白细胞介素10的作用”的这篇文章中,Sundeep Keswani和共同作者探究了成功的伤口愈合所涉及的复杂过程,细胞类型,生长因子和其它物质。

科学家探讨了胎儿皮肤无疤痕愈合的能力,研究结果提示IL-10或作为一种抗瘢痕形成剂。(生物谷Bioon.com)

Regenerative Wound Healing: The Role of Interleukin-10

KingAlice, BalajiSwathi, LeLouis D., CrombleholmeTimothy M., et al.

Significance: Postnatal wounds heal with characteristic scar formation. In contrast, the mid-gestational fetus is capable of regenerative healing, which results in wound repair that is indistinguishable from uninjured skin. However, the underlying mechanisms of fetal regenerative phenotype are unknown. Recent Advances: The potent anti-inflammatory cytokine, interleukin-10 (IL-10), plays an essential role in the ability of the fetus to heal regeneratively and has been shown to recapitulate scarless healing in postnatal tissue. IL-10's ability to facilitate regenerative healing is likely a result of pleiotropic effects, through regulation of the inflammatory response, as well as novel roles as a regulator of the extracellular matrix, fibroblast cellular function, and endothelial progenitor cells. Overexpression of IL-10 using a variety of methods has been demonstrated to recapitulate the fetal regenerative phenotype in post-natal tissue, in conjunction with promising results of Phase II clinical trials using recombinant IL-10. Critical Issues: Successful wound healing is a complex process that requires coordination of multiple growth factors, cell types, and extracellular cellular matrix components. IL-10 has been demonstrated to be critical in the fetus' intrinsic ability to heal without scars, and, further, can induce scarless healing in postnatal tissue. The mechanisms through which IL-10 facilitates this regeneration are likely the result of IL-10's pleiotropic effects. Efforts to develop IL-10 as an anti-scarring agent have demonstrated promising results. Future Directions: Further studies on the delivery, including dose, route, and timing, are required in order to successfully translate these promising findings from in vitro studies and animal models into clinical practice. IL-10 holds significant potential as an anti-scarring therapeutic.

温馨提示:87%用户都在生物谷APP上阅读,扫描立刻下载! 天天精彩!


相关标签

最新会议 培训班 期刊库